REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,075,678 | +7.4% | 10,550 | +5.0% | 0.07% | +169.2% |
| Q1 2021 | $1,002,000 | +34.5% | 10,050 | +31.3% | 0.03% | -27.8% |
| Q3 2020 | $745,000 | +1141.7% | 7,652 | +1887.5% | 0.04% | +1100.0% |
| Q2 2020 | $60,000 | -98.5% | 385 | -98.0% | 0.00% | -98.0% |
| Q4 2019 | $3,971,000 | -8.2% | 19,423 | -63.9% | 0.15% | -22.6% |
| Q3 2019 | $4,326,000 | +7.4% | 53,876 | +26.2% | 0.20% | -1.5% |
| Q2 2019 | $4,028,000 | +1479.6% | 42,694 | +244.0% | 0.20% | +942.1% |
| Q1 2018 | $255,000 | – | 12,412 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |